文献速递慢性肾脏病

尿Dickkopf-3可预测普通人群GFR下降

Urinary Dickkopf-3 Predicts GFR Loss in the General Population.
PubMed 文献 · Kidney Int Rep · 2025-07-15

这项前瞻性队列研究纳入1316名55–69岁参与者,随访5.3年,采用碘海醇清除率测量GFR,评估尿DKK3/Cr水平与GFR下降的关系。结果显示,高uDKK3/Cr组GFR年下降速度快0.63 ml/min per 1.73 m2(P=0.049),加速下降风险OR为2.68(P=0.03),提示uDKK3可作为早期识别快速GFR丢失风险的生物标志物。

要点

  • 高uDKK3/Cr组较未检出组GFR年下降快0.63 ml/min per 1.73 m2。
  • 高uDKK3/Cr组加速GFR下降的OR为2.68。
  • uDKK3预测价值独立于传统CKD危险因素。

核心结论

  • uDKK3升高与更快的GFR下降相关,且独立于传统CKD危险因素,提示其可作为早期识别快速GFR丢失风险的有前景的生物标志物。

研究设计与样本

  • 前瞻性队列研究,纳入1316名55–69岁参与者,来自RENIS研究(2014–2015),随访5.3年,进行1–3次碘海醇清除率GFR测量。

主要发现

  • 平均年GFR下降率为-1.33 ml/min per 1.73 m2。
  • 1112人uDKK3/Cr未检出,167人低水平(可检出<400 pg/mg),37人高水平(≥400 pg/mg)。
  • 高uDKK3/Cr组中63%为男性,收缩压和舒张压更高,尽管降压药使用相当。
  • 高uDKK3/Cr组较未检出组GFR年下降快0.63 ml/min per 1.73 m2(P=0.049)。
  • 高uDKK3/Cr组加速GFR下降的OR为2.68(P=0.03)。

关键数值与推荐

  • uDKK3/Cr分组:未检出、低水平(可检出<400 pg/mg)、高水平(≥400 pg/mg)。
  • 加速GFR下降定义为下降幅度最大的前10%。

临床怎么用

  • 在普通人群55–69岁个体中,检测uDKK3/Cr可能有助于识别GFR快速下降高风险者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Chronic kidney disease (CKD) affects > 800 million people globally, with prevalence expected to increase, emphasizing the need for effective early detection and management strategies. Urinary Dickkopf-3 (uDKK3), a profibrotic glycoprotein from renal tubular cells, has been linked to acute kidney injury (AKI) and CKD progression. This study assesses uDKK3 as a biomarker for predicting glomerular filtration rate (GFR) decline in the general population. METHODS: We conducted a prospective cohort study with 1316 participants aged 55 to 69 years from the Renal Iohexol Clearance Survey (RENIS) (2014-2015), undergoing 1 to 3 GFR measurements using iohexol clearance over 5.3 years. uDKK3 levels were normalized to creatinine (Cr), categorizing participants by uDKK3/Cr levels: undetectable, low (detectable < 400 pg/mg), and high (≥ 400 pg/mg). Linear mixed models were used to evaluate the relationship between uDKK3/Cr levels and GFR decline rate. Logistic regression was used to examine the association between uDKK3/Cr groups and accelerated GFR decline, defined as the top 10% steepest declines. RESULTS: The mean annual GFR decline rate was -1.33 ml/min per 1.73 m2. A total of 1112 individuals had undetectable uDKK3/Cr levels, 167 had low levels, and 37 had high levels. The high uDKK3/Cr level group comprised 63% men and had higher systolic and diastolic blood pressure (BP) levels, despite comparable use of antihypertensive medications. Higher baseline uDKK3/Cr levels significantly correlated with faster GFR decline, independent of traditional CKD risk factors. Participants with high uDKK3/Cr levels had an annual GFR reduction 0.63 ml/min per 1.73 m2 faster than those with undetectable levels (P = 0.049). High uDKK3/Cr levels had an odds ratio of 2.68 for accelerated GFR decline, compared with those with undetectable levels (P = 0.03). CONCLUSION: Elevated uDKK3 levels were linked to steeper GFR decline, independent of conventional CKD risk factors, confirming uDKK3 as a promising biomarker for early identification of individuals at risk for rapid GFR loss.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Norvik JV, Fliser D, Eriksen BO, et al. Urinary Dickkopf-3 Predicts GFR Loss in the General Population. Kidney Int Rep. 2025. PMID: 41141539. doi:10.1016/j.ekir.2025.07.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。